Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis

OBJECTIVES: Whether patients with RA benefit from repeated trials of biologic or targeted synthetic DMARDs (b/tsDMARDs) after three or more attempts is unknown. We aimed to describe treatment outcomes in each line of b/tsDMARD therapy. METHODS: Using data from the British Society for Rheumatology Bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Sizheng Steven, Kearsley-Fleet, Lianne, Bosworth, Ailsa, Watson, Kath, Hyrich, Kimme L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707051/
https://www.ncbi.nlm.nih.gov/pubmed/35357421
http://dx.doi.org/10.1093/rheumatology/keac190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707051/
https://www.ncbi.nlm.nih.gov/pubmed/35357421
http://dx.doi.org/10.1093/rheumatology/keac190

Ejemplares similares